CD274 and head and neck squamous cell carcinoma: This knowledge can help to optimize radio- immunotherapy combination strategies (e.g. timing) in HNSCC and longitudinal assessment of the TME by means of PD-L1 imaging may serve as a biomarker in clinical translation.